TBPH (Theravance Biopharma) Tax Rate %: -23.11% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TBPH Theravance Biopharma Inc TBPH
72 GF Score
Price $17.04
GF Value $17.22
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Theravance Biopharma Tax Rate %?

Theravance Biopharma TBPH -0.06% 72 Tax Rate % is -23.11% as of Jun. 2026. GuruFocus rates TBPH with a GF Score™ of 72/100 and a GF Value™ of $17.22 (Fairly Valued). The stock has 2 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Theravance Biopharma's Tax Expense for the three months ended in Jun. 2026 was $1.1 Mil. Theravance Biopharma's Pre-Tax Income for the three months ended in Jun. 2026 was $-4.8 Mil. Therefore, Theravance Biopharma's Tax Rate % for the quarter that ended in Jun. 2026 was -23.11%.

Theravance Biopharma Tax Rate % Related Terms

Theravance Biopharma Tax Rate % Historical Data

* Premium members only.

The historical data trend for Theravance Biopharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theravance Biopharma Tax Rate % Chart

Theravance Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 -0.01 -12.02 -26.46 18.07

Theravance Biopharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.09 225.13 16.48 23.76 -23.11
TBPH
72GF Score
Theravance Biopharma Inc TBPH
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Theravance Biopharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Theravance Biopharma's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=23.352/129.247
=18.07 %

Theravance Biopharma's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=1.107/-4.791
=-23.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of -23.11% mean?
Theravance Biopharma (TBPH) has a Tax Rate % of -23.11% as of Jun. 2026.
Is Theravance Biopharma's Tax Rate % too high?
Theravance Biopharma's current Tax Rate % is -23.11%. Overall, Theravance Biopharma has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Theravance Biopharma's Tax Rate % compare to ACRS and SGP?
Theravance Biopharma's Tax Rate % of -23.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Theravance Biopharma's current Tax Rate % is -23.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Theravance Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Theravance Biopharma (TBPH) is currently considered Fairly Valued. The stock's GF Value™ is $17.22, compared to a current price of $17.04 — trading 1% below its estimated fair value. The current Tax Rate % is -23.11%. Theravance Biopharma's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Theravance Biopharma (TBPH), the current Tax Rate % is -23.11% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Theravance Biopharma (TBPH) Overvalued in 2026?

Based on GuruFocus' analysis, Theravance Biopharma stock appears to be undervalued. The current stock price of $17.04 is trading 1% below its estimated GF Value™ of $17.22. GuruFocus considers Theravance Biopharma to be Fairly Valued.

Key valuation signals for TBPH:

  • Tax Rate %: -23.11%
  • GF Value™: $17.22 vs. price of $17.04 (1% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the TBPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Theravance Biopharma Business Description

Other Exchanges 0TB:Germany
Address C/O Theravance Biopharma US, LLC, 901 Gateway Boulevard, South San Francisco, CA, USA, 94080
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
72GF Score

Get the complete analysis for TBPH

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.04
Price
$17.22
GF Value